Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Financial Disclosure
The University of Florida Medical School provided all outside activity disclosure data for faculty from forms filed from 2016 through June 2019. Faculty are required to report outside activities that could give rise to an appearance of conflict of interest and get approval for them.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Coy Heldermon
University of Florida, Department: Md Hematology/oncology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Coleman Experts
Investment research consulting regarding breast cancer and lysosomal storage disorders
by phone, 1 hour per episode, uncertain number of episodes but currently 2 planned.
Filed on October 19, 2017.
Tell us what you know about Coy Heldermon's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Coy Heldermon”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Coy Heldermon | University of Florida | Conflict of Interest | Lacerta Therapeutics, Inc. | $0 - $4,999 |
| Coy Heldermon | University of Florida | Financial Disclosure | Cardinal Health Specialty Solutions | |
| Coy Heldermon | University of Florida | Financial Disclosure | Elite Medical Experts | |
| Coy Heldermon | University of Florida | Financial Disclosure | mallinckrodt ARD Inc. | |
| Coy Heldermon | University of Florida | Financial Disclosure | Geno-immune Medical Institute | |
| Coy Heldermon | University of Florida | Financial Disclosure | Guidepoint | |
| Coy Heldermon | University of Florida | Financial Disclosure | Genzyme Corporation (Biomarin-Genzyme) | |
| Coy Heldermon | University of Florida | Conflict of Interest | Lacerta Therapeutics, Inc. | $0 - $4,999 |
| Coy Heldermon | University of Florida | Financial Disclosure | Genzyme Corporation (Biomarin-Genzyme) |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.